GPER1, a third novel estrogen receptor that binds to estrogen, has recently been found to have elevated expression in lung cancer tissue than in normal lung tissue (4), and to promote proliferation, invasion, and migration of NSCLC cells induced by E2 and its selective agonist G1 (3). This evidence concerns the gene ESR1 and lung carcinoma.